Newswise — CHICAGO (July 26, 2018) — While anyone can develop skin cancer, regardless of age, race or gender, certain groups of people have a higher risk of getting the disease than others. Because organ transplant patients must take medication to suppress their immune system, they are among those with an increased risk — and the skin cancers that develop in these patients are often more aggressive, with a poor prognosis.

“Individuals who receive organ transplants need to take immunosuppressive medications for the rest of their lives, and this makes it more difficult for their bodies to fight disease, including skin cancer,” says board-certified dermatologist Christina Lee Chung, MD, FAAD, former director of the Drexel Dermatology Center for Transplant Patients in Philadelphia. “On top of that, some of these medications make the skin more sensitive to the sun’s harmful ultraviolet rays, which can further increase patients’ skin cancer risk.”

According to Dr. Chung, organ transplant patients have a higher skin cancer risk if they have fairer skin, are male, have a pre-transplant history of skin cancer, receive their organ at age 50 or older, or have a lung or heart transplant. While skin cancer can affect organ transplant patients of any skin tone, she says, specific risk factors in these patients may vary based on their race. For example, she says, Caucasian patients have the highest skin cancer risk and are most likely to develop the disease in sun-exposed areas, as are Asian transplant patients.

In contrast, Latino and black transplant patients are more likely to develop skin cancer in areas that are protected from the sun, Dr. Chung says, with black patients especially at risk for human papillomavirus-related cancers in the genital area. While more research will be necessary to establish the unique skin cancer risk factors in organ transplant patients with darker skin tones, she says, a preliminary study she conducted at Drexel University suggests that those risk factors may include a history of warts, emigration to the U.S. from a country near the equator, a history of sexually transmitted infections, or a history of medical conditions that require immunosuppressive medications to be taken before transplant surgery.

“When it comes to skin cancer risk factors in this population, it’s not one-size-fits-all,” Dr. Chung says. “However, it’s important for all organ transplant patients, regardless of skin tone, to recognize their skin cancer risk; protect themselves from sun exposure, which could further increase that risk; and regularly examine their entire body, including the genital area, for signs of skin cancer so they can detect the disease early, when it’s most treatable.”

The American Academy of Dermatology recommends a comprehensive sun protection plan that involves seeking shade, wearing protective clothing, and generously applying a broad-spectrum, water-resistant sunscreen with an SPF of 30 or higher to exposed skin. The AAD also recommends that everyone conduct regular skin cancer self-exams, asking a partner to help them check hard-to-see areas like their back. Anyone who notices any new spots, any suspicious spots that are different from the others on their skin, or anything changing, itching or bleeding should see a board-certified dermatologist.

“In addition to taking action toward skin cancer prevention and detection, organ transplant patients also should establish a relationship with a board-certified dermatologist after their procedure,” Dr. Chung says. “A dermatologist can evaluate your unique risk factors and help you ensure the health of your largest organ: your skin.”



More Information

U004–Evidence-Based Management of Transplant Recipients: Transplant Skin Cancer Network

Organ transplant recipients benefit from seeing a dermatologist

Skin cancer in people of color

About the AAD

Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential and most representative of all dermatologic associations. With a membership of more than 19,000 physicians worldwide, the AAD is committed to advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the AAD at (888) 462-DERM (3376) or Follow the AAD on Facebook (American Academy of Dermatology), Twitter (@AADskin) or YouTube (AcademyofDermatology).

Meeting Link: 2018 AAD Summer Meeting